Keyphrases
ACTA2
14%
Adult Lung
14%
AEC2
100%
Alveolar Epithelial Injury
14%
Alveolar Epithelium
14%
Alveolar Size
14%
Bleomycin
57%
Bleomycin-induced Lung Injury
100%
Bleomycin-induced Pulmonary Fibrosis
14%
Collagen Deposition
28%
Conditional Knockout
14%
Dose Reduction
14%
FGFR Inhibition
14%
Fibroblast Growth Factor Receptor 1 (FGFR1)
14%
Fibroblast Growth Factor Receptor 2 (FGFR2)
100%
Fibroblast Growth Factor Receptor 3 (FGFR3)
42%
Fibroblast Growth Factor Signaling
28%
Fibrosis
28%
Flow Cytometry
14%
Gene Expression
28%
Homeostasis
100%
Hyperoxia
14%
Immunofluorescence
14%
Increased Mortality
28%
Intratracheal
14%
Knock-in Mouse Model
28%
Lung Edema
14%
Lung Injury
57%
Protective Effect
14%
Pulmonary Fibrosis
14%
SP-C
14%
Surfactant Protein C Gene
14%
Total Flow
14%
Total Protein
14%
Medicine and Dentistry
Alveolar Epithelium
25%
Bleomycin
100%
Bleomycin-Induced Lung Injury
100%
Bleomycin-Induced Pulmonary Fibrosis
25%
Cell Damage
25%
Drug Dose Reduction
25%
Epithelial Cell
25%
Experimental Lung Injury
25%
Fibroblast Growth Factor
50%
Fibroblast Growth Factor Receptor 1
25%
Fibroblast Growth Factor Receptor 2
100%
Fibroblast Growth Factor Receptor 3
25%
Fibrosis
50%
Flow Cytometry
25%
Gene Expression
50%
Homeostasis
100%
Hyperoxia
25%
Immunofluorescence
25%
Lung
25%
Protein
25%
Pulmonary Edema
25%
Pulmonary Fibrosis
25%
Surfactant Protein C
50%
Pharmacology, Toxicology and Pharmaceutical Science
Bleomycin
100%
Bleomycin-Induced Lung Injury
100%
Bleomycin-Induced Pulmonary Fibrosis
25%
Experimental Lung Injury
25%
Fibroblast Growth Factor
50%
Fibroblast Growth Factor Receptor 1
25%
Fibroblast Growth Factor Receptor 2
100%
Fibroblast Growth Factor Receptor 3
25%
Fibrosis
50%
Flow Cytometry
25%
Knockout Mouse
50%
Lung Edema
25%
Lung Fibrosis
25%
Protein
25%
Surfactant Protein C
50%